Results

Total Results: 2,080 records

Showing results for "drug".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/emt-naloxon_research-protocol.pdf
    November 29, 2016 - Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014. … Drug Alcohol Depend. 2016 Jun 1;163:16-23. doi: 10.1016/j.drugalcdep.2016.02.042. … Food and Drug Administration; 2014. … Food and Drug Administration; 2015. … Am Health Drug Benefits. 2015 Oct;8(6 Suppl 3):S51-63. PMID: 26629261. 30.
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
    August 01, 2020 - drug users: a randomized controlled trial. … Drug and alcohol dependence. 2015;147:122-9. … Drug and opioid-involved overdose deaths—United States, 2013–2017. … Int J Drug Policy. 2018;56:73-80. doi: https://dx.doi.org/10.1016/j.drugpo.2018.03. 012. … drug users: a randomized controlled trial.
  3. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - FDA approves Qsymia, a weight-loss drug. [internet]. … Food and Drug Administration (FDA); 2014 Dec 23 [accessed 2015 Feb 03]. [5 p]. … Ther Adv Drug Saf. 2013;4(4):171-81. … Novo Nordisk to promote drug to treat obesity in United States. [internet]. … Medica 2015 comprehensive preferred drug list (PDL).
  4. effectivehealthcare.ahrq.gov/products/pneumonia-antibiotic-treatment/research-protocol
    July 19, 2013 - dosing of antibiotics has been associated with poorer clinical outcomes and increased incidences of drug … PK is the study of the time course of drug absorption, distribution, metabolism, and excretion. … Antibiotics for which PK/PD measures could be used   Drug Class Drug Group Drug* *Drug names … Optimizing drug exposure to minimize selection of antibiotic resistance. … Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.
  5. Ced -Appendix-2 (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced%20-appendix-2.xlsx
    October 12, 2022 - Application of CED to an on-label use of a drug or biological is contrary to the requirements of the … controlled trials (RTCs) and to incorporate real-world evidence (RWE) Exclude on-label use of Food and Drug … drugs and biologicals be excluded from CED restrictions Application of CED to an on-label use of a drug … Requirements for post-FDA-approval real-world evidence development that is based on coverage to label for any drug
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/survival-quality_research.pdf
    April 01, 2013 - Food and Drug Administration Silver Spring, MD Lynne Wagner, Ph.D. … PFS - QOL association Author, Year Cancer Type Exp Drug vs. … Endpoints for assessing drug activity in clinical trials. … Food and Drug Administration between July 2005 and December 2007. … Food and Drug Administration.
  7. S66 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s66.pdf
    October 01, 2007 - Reform of drug regulation—beyond an indepen- dent drug-safety board. … The epidemiology of drug treatment failure in rheumatoid arthritis. … Phar- macoepidemiol Drug Saf. 2006;15:565–574. 20. Steiner JF, Earnest MA. … Coding accuracy of administra- tive drug claims in the Ontario Drug Benefit database. … Trends in prescription drug expenditures by Medicaid enrollees.
  8. S158 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
    October 01, 2007 - DrPH,*§¶ Jerry Avorn, MD,* and Sebastian Schneeweiss, MD*� Background: Nonexperimental studies of drug … effects in large automated databases can provide timely assessment of real-life drug use, but are prone … Paradoxical relations of drug treatment with mortality in older persons. … Colorectal cancer after start of nonsteroidal anti-inflammatory drug use. … Pharmacoepidemiol Drug Saf. 2006;15:291–303. 10. Angrist JD, Imbens GW, Rubin DB.
  9. effectivehealthcare.ahrq.gov/products/observational-research-scores/research
    May 15, 2012 - If a patient has high cholesterol and is on other medications, then the potential for drug-drug interactions … For example, perhaps an adverse effect of a drug is only apparent when the drug is prescribed to people … Pharmacoepidemiol Drug Safety 2005;14(7):465-76. … Pharmacoepidemiol Drug Saf 2005;14:S21. … Pharmacoepidemiol Drug Saf 2006; 15(5): 291–303.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
    December 30, 2015 - Once a drug is out of patent there is no incentive to finance proper modern studies. … We included any drug available in the United States if there were eligible trials. … ‘As needed’ use made insomnia WORSE on nights the drug was omitted. … on nights the drug is not taken. … and the placebo group after drug withdrawal.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-211-rheumatoid-arthritis-disposition-comments.pdf
    December 20, 2018 - Disposition of Comments for CER 211: Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review … Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update. … Drug Therapy for Rheumatoid Arthritis in Adults: An Update. … This should be revised to read the correct drug. … Additionally, drug classes were not used as part of the search string.
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/suda-final-protocol.pdf
    October 02, 2018 - Drug use and sexually transmitted diseases among female and male arrested youths. … drug use. … Drug Overdose Deaths among Adolescents Aged 15- 19 in the United States: 1999-2015. … SBIRT for adolescent drug and alcohol use: current status and future directions. … National Institute on Drug Abuse.
  13. effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug … Biogen (Cambridge, MA) has advanced this candidate drug to phase III testing, despite initial analysis … to have antiamyloidogenic properties, and oral ibuprofen, a common nonsteroidal anti-inflammatory drug … the widely- used cough suppressant dextromethorphan with quinidine, a class Ia antiarrhythmic drug, … AVP-786’s mechanism of action is unknown, but developers designed the drug using deuterium-modified
  14. effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
    January 01, 2012 - coverage and formulary status of the drug on the patient’s drug plan … Drug coverage guidelines. [internet]. … Food and Drug Administration (FDA); 2011 Apr 5. … Anthem Blue Cross California drug list. … Drug list search results: Dificid. [internet].
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
    October 08, 2014 - These patients present special challenges as there are drug-drug interactions between CNIs and protease … Studies that only evaluate drug pharmacokinetics will also be excluded. … Ther Drug Monit. 2009;31:139-52. 9. Bouamar R, Shuker N, Hesselink DA, et al. … Drug-drug interactions between antiretroviral and immunosuppressive agents in HIV-infected patients … monitoring terms 'drug monitoring'/exp OR 'drug monitoring' OR ((drug OR therapy OR therapeutic)
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_disposition-comments.pdf
    December 01, 2011 - It would be better if it could be divided into 2 reports - one way to do this would be drug vs drug … Peer Reviewer #5 Methods Pg. 33, line 28 “…and drug interactions.” … 'Drug Interactions' is not really an outcome measure. … or page 49, line 37-57 Direct evidence was considered sufficient to conduct meta- analyses for six drug-drug … Might want to say that this is probably only possible with this specific drug.
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-treatments-chronic-pain-protocol.pdf
    December 19, 2018 - Intermediate outcomes such as pharmacokinetic and pharmacodynamic measures, drug-drug interaction markers … The DAWN Report: Highlights of the 2010 Drug Abuse Warning Network (DAWN) findings on drug-related emergency … Drug Overdose/ 25. or/17-24 26. risk$.ti,ab,kf. 27. … Drug Monitoring/ 21. (urine adj7 (screen$ or test$ or detect$)).ti,ab,kf. 22. … Drug Overdose/ 27. or/17-26 28. Substance Abuse Detection/ 29.
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/deprescribing-protocol.pdf
    July 01, 2023 - polypharmacy3 and 58% to PIMs.4 Of concern, both polypharmacy and PIMs are associated with adverse drug … potential to improve multiple aspects of patient safety and quality of care, including by reducing drug … Adverse drug events in ambulatory care. … Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. … Reducing Adverse Drug Events in Older Adults.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
    August 01, 2017 - Food and Drug Administration (FDA) has approved several prescription drugs for insomnia, typically … Drug General Adult Population Adults 55 Years of Age and Older Global Outcomes Sleep Outcomesa Global … Food and Drug Administration (FDA) for insomnia. d Other benzodiazepines include drugs approved by … Food and Drug Administration Label Information Drug Class Drug Common Effectsa Serious Effectsb Nonbenzo … insomnia, nausea �� Potential impairment of activities requiring complete mental alertness after drug
  20. effectivehealthcare.ahrq.gov/products/urinary-incontinence-treatment/research
    April 09, 2012 - Data Sources We searched major electronic bibliographic databases, the FDA (Food and Drug Administration

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: